Although the status of circulating and lung ACE levels in COVID-19 patients is unclear, the ability of SARS-CoV-2 binding specifically to ACE2 decreases its expression and activity suggesting upregulation of ACE/Ang-II-mediated activities. This evidence concerns the gene ACE and COVID-19.